ENVOY MEDICAL, INC. Capital Expenditures
ENVOY MEDICAL, INC. (COCH) reported Capital Expenditures of $6.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-10
- ENVOY MEDICAL, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $172.00K.
- ENVOY MEDICAL, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ENVOY MEDICAL, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $1.00K.
- ENVOY MEDICAL, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $6.00K.
- ENVOY MEDICAL, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $153.00K, a 29.82% decline from fiscal 2022.
- ENVOY MEDICAL, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $218.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.00K 10-Q · filed 2026-08-10 | |||
| 2025-12-31 | $172.00K derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12 | $172.00K derived: sum of 2 quarters · filed 2026-06-12 | $173.00K derived: sum of 3 quarters · filed 2026-08-10 | $179.00K POS AM · filed 2026-06-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.00K derived: sum of 2 quarters · filed 2026-08-10 | $7.00K 10-Q · filed 2025-11-10 | -$527.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $1.00K derived: 10-Q 6 month − POS AM 3 month · filed 2026-08-10 | $7.00K 10-Q · filed 2026-08-10 | -$527.00K derived: sum of 3 quarters · filed 2026-08-10 | $630.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $6.00K POS AM · filed 2026-06-12 | -$528.00K derived: sum of 2 quarters · filed 2026-06-12 | $629.00K derived: sum of 3 quarters · filed 2026-06-12 | |
| 2024-12-31 | -$534.00K derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12 | $623.00K derived: sum of 2 quarters · filed 2026-06-12 | $980.00K POS AM · filed 2026-06-12 | |
| 2024-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.51M 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | $357.00K 10-Q · filed 2025-07-31 | |||
| 2023-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $83.00K derived: sum of 2 quarters · filed 2025-03-31 | $94.00K derived: sum of 3 quarters · filed 2025-03-31 | $153.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $73.00K derived: sum of 2 quarters · filed 2024-11-14 | $132.00K 10-Q · filed 2024-11-14 | $173.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $70.00K 10-Q · filed 2024-08-12 | $111.00K derived: sum of 3 quarters · filed 2024-08-12 | |
| 2023-03-31 | $59.00K 10-Q · filed 2024-05-15 | $100.00K derived: sum of 2 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $41.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-01 | $218.00K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $177.00K 10-Q/A · filed 2024-01-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |